{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:31:15Z","timestamp":1782833475312,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11239-021-02511-6","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T08:02:40Z","timestamp":1624953760000},"page":"202-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-2744","authenticated-orcid":false,"given":"Sagar K.","family":"Chokshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Gaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Krill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"1","key":"2511_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","volume":"41","author":"JA Heit","year":"2016","unstructured":"Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41(1):3\u201314","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"2511_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529\u2013535","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2511_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ 3rd (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160(6):809\u2013815","journal-title":"Arch Intern Med"},{"issue":"6","key":"2511_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6):715\u2013722","journal-title":"JAMA"},{"issue":"1","key":"2511_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","volume":"22","author":"T Wun","year":"2009","unstructured":"Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 22(1):9\u201323","journal-title":"Best Pract Res Clin Haematol"},{"issue":"16","key":"2511_CR6","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1200\/JCO.2008.16.1109","volume":"26","author":"C Fotopoulou","year":"2008","unstructured":"Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B et al (2008) Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum\/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol 26(16):2683\u20132689","journal-title":"J Clin Oncol"},{"issue":"25","key":"2511_CR7","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT Sorensen","year":"2000","unstructured":"Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846\u20131850","journal-title":"N Engl J Med"},{"issue":"3","key":"2511_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ygyno.2007.02.024","volume":"105","author":"AO Rodriguez","year":"2007","unstructured":"Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH (2007) Venous thromboembolism in ovarian cancer. Gynecol Oncol 105(3):784\u2013790","journal-title":"Gynecol Oncol"},{"issue":"2 Suppl","key":"2511_CR9","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S\u2013e227S77S","journal-title":"Chest"},{"issue":"8","key":"2511_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bjc.6603989","volume":"97","author":"T Satoh","year":"2007","unstructured":"Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S et al (2007) High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer 97(8):1053\u20131057","journal-title":"Br J Cancer"},{"issue":"4","key":"2511_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/ijgc-2019-000980","volume":"30","author":"JR Salinaro","year":"2020","unstructured":"Salinaro JR, McQuillen K, Stemple M, Boccaccio R, Ehrisman J, Lorenzo AM et al (2020) Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Int J Gynecol Cancer 30(4):491\u2013497","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"2511_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/AOG.0000000000001980","volume":"129","author":"PS Greco","year":"2017","unstructured":"Greco PS, Bazzi AA, McLean K, Reynolds RK, Spencer RJ, Johnston CM et al (2017) Incidence and timing of thromboembolic events in patients with ovarian cancer undergoing neoadjuvant chemotherapy. Obstet Gynecol 129(6):979\u2013985","journal-title":"Obstet Gynecol"},{"issue":"17","key":"2511_CR13","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1200\/JCO.2010.34.0984","volume":"29","author":"PL den Exter","year":"2011","unstructured":"den Exter PL, Hooijer J, Dekkers OM, Huisman MV (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 29(17):2405\u20132409","journal-title":"J Clin Oncol"},{"issue":"5","key":"2511_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/AOG.0b013e318232a394","volume":"118","author":"DD Rahn","year":"2011","unstructured":"Rahn DD, Mamik MM, Sanses TV, Matteson KA, Aschkenazi SO, Washington BB et al (2011) Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gynecol 118(5):1111\u20131125","journal-title":"Obstet Gynecol"},{"issue":"Suppl 4","key":"2511_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","volume":"123","author":"RH White","year":"2009","unstructured":"White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl 4):S11\u2013S17","journal-title":"Thromb Res"},{"issue":"1","key":"2511_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ygyno.2011.11.025","volume":"125","author":"M Terplan","year":"2012","unstructured":"Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19\u201324","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2511_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jso.20932","volume":"97","author":"JK Chan","year":"2008","unstructured":"Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS (2008) Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol 97(2):103\u2013107","journal-title":"J Surg Oncol"},{"issue":"8","key":"2511_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1055\/s-0029-1145257","volume":"34","author":"G Lippi","year":"2008","unstructured":"Lippi G, Franchini M (2008) Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 34(8):747\u2013761","journal-title":"Semin Thromb Hemost"},{"issue":"2 Pt 1","key":"2511_CR19","first-page":"429","volume":"110","author":"Committee on Practice Bulletins\u2013Gynecology ACoO, Gynecologists","year":"2007","unstructured":"Committee on Practice Bulletins\u2013Gynecology ACoO, Gynecologists (2007) ACOG Practice Bulletin No. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 110(2 Pt 1):429\u2013440","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2511_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38(5):496\u2013520","journal-title":"J Clin Oncol"},{"issue":"1","key":"2511_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ygyno.2020.11.020","volume":"160","author":"GM Gressel","year":"2021","unstructured":"Gressel GM, Marcus JZ, Mullen MM, Sinno AK (2021) Direct oral anticoagulant use in gynecologic oncology: a Society of Gynecologic Oncology Clinical Practice Statement. Gynecol Oncol 160(1):312\u2013321","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2511_CR22","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902\u20134907","journal-title":"Blood"},{"issue":"24","key":"2511_CR23","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R et al (2010) Prediction of venous thromboembolism in cancer patients. Blood 116(24):5377\u20135382","journal-title":"Blood"},{"issue":"6","key":"2511_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","volume":"104","author":"FI Mulder","year":"2019","unstructured":"Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N et al (2019) The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 104(6):1277\u20131287","journal-title":"Haematologica"},{"issue":"8","key":"2511_CR25","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/jth.14824","volume":"18","author":"N van Es","year":"2020","unstructured":"van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M et al (2020) The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis. J Thromb Haemost 18(8):1940\u20131951","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2511_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1200\/JCO.2014.58.6537","volume":"33","author":"A Srikanthan","year":"2015","unstructured":"Srikanthan A, Tran B, Beausoleil M, Jewett MA, Hamilton RJ, Sturgeon JF et al (2015) Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy. J Clin Oncol 33(6):582\u2013587","journal-title":"J Clin Oncol"},{"issue":"1","key":"2511_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cam4.2674","volume":"9","author":"B Tran","year":"2020","unstructured":"Tran B, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C et al (2020) Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: a study by the global germ cell cancer group (G3). Cancer Med 9(1):116\u2013124","journal-title":"Cancer Med"},{"issue":"3","key":"2511_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632\u2013634","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2511_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ygyno.2016.11.036","volume":"144","author":"EL Barber","year":"2017","unstructured":"Barber EL, Clarke-Pearson DL (2017) Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol 144(2):420\u2013427","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02511-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:04:55Z","timestamp":1643205895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02511-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"8 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Cooper Health System approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}